Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 From a choleretic to an immunomodulator: historical review of ursodeoxycholic acid as a medicament.

× No keyword cloud information.

9 in total

1. Current status of therapy in autoimmune liver disease.

Authors: Gideon M Hirschfield; Nadya Al-Harthi; E Jenny Heathcote
Journal: Therap Adv Gastroenterol Date: 2009-01 Impact factor: 4.409

Review 2. Ursodeoxycholic acid in chronic hepatitis C.

Authors: Raoul Poupon; Lawrence Serfaty
Journal: Gut Date: 2007-12 Impact factor: 23.059

3. Antiviral and anti-inflammatory effects of rosmarinic acid in an experimental murine model of Japanese encephalitis.

Authors: Vivek Swarup; Joydeep Ghosh; Soumya Ghosh; Amit Saxena; Anirban Basu
Journal: Antimicrob Agents Chemother Date: 2007-06-18 Impact factor: 5.191

Review 4. Ursodeoxycholic acid therapy in gallbladder disease, a story not yet completed.

Authors: Michele Pier Luca Guarino; Silvia Cocca; Annamaria Altomare; Sara Emerenziani; Michele Cicala
Journal: World J Gastroenterol Date: 2013-08-21 Impact factor: 5.742

Review 5. Key discoveries in bile acid chemistry and biology and their clinical applications: history of the last eight decades.

Authors: Alan F Hofmann; Lee R Hagey
Journal: J Lipid Res Date: 2014-05-17 Impact factor: 5.922

6. Metal Zn(II), Cu(II), Ni (II) complexes of ursodeoxycholic acid as putative anticancer agents.

Authors: Lora Dyakova; Daniela-Cristina Culita; Gabriela Marinescu; Marin Alexandrov; Reni Kalfin; Luminita Patron; Radostina Alexandrova
Journal: Biotechnol Biotechnol Equip Date: 2014-08-30 Impact factor: 1.632

7. Effectiveness of hepatoprotective drugs for anti-tuberculosis drug-induced hepatotoxicity: a retrospective analysis.

Authors: Zenya Saito; Yugo Kaneko; Akira Kinoshita; Yusuke Kurita; Kyuto Odashima; Tsugumi Horikiri; Yutaka Yoshii; Aya Seki; Yoshitaka Seki; Hiroshi Takeda; Kazuyoshi Kuwano
Journal: BMC Infect Dis Date: 2016-11-11 Impact factor: 3.090

8. Ursodeoxycholic acid ameliorates fructose-induced metabolic syndrome in rats.

Authors: Amr A A Mahmoud; Shimaa M Elshazly
Journal: PLoS One Date: 2014-09-09 Impact factor: 3.240

9. Ursodeoxycholic Acid Protects Against Arsenic Induced Hepatotoxicity by the Nrf2 Signaling Pathway.

Authors: Chao Li; Sheng Zhang; Liming Li; Qing Hu; Shen Ji
Journal: Front Pharmacol Date: 2020-10-16 Impact factor: 5.810

9 in total